Compounds > bisbenzimidazole
Page last updated: 2024-10-23

bisbenzimidazole and Atherosclerotic Parkinsonism

bisbenzimidazole has been researched along with Atherosclerotic Parkinsonism in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woodgate, A1
MacGibbon, G1
Walton, M1
Dragunow, M1

Other Studies

1 other study available for bisbenzimidazole and Atherosclerotic Parkinsonism

ArticleYear
The toxicity of 6-hydroxydopamine on PC12 and P19 cells.
    Brain research. Molecular brain research, 1999, May-21, Volume: 69, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aurintricarboxylic Acid; Biological Transport; Bisbenzimi

1999